HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated Biopharma, Inc. (Nasdaq:INBP) today announced the appointment of Robert L. Erwin as President of its wholly-owned subsidiary, InB:Biotechnologies, Inc. (“Biotech”). Mr. Erwin will lead the implementation of INBP’s plant-based vaccine and therapeutics strategy, and guide the development of Biotech as an independent company.
